|
|
|
41
|
A5015
|
DIOVAN 160MG TAB (NVS) VALSARTAN
|
VALSARTAN
|
DIOVAN
|
14'S
|
A
|
9.08
|
0.6486
|
TAB
|
30
|
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-09-06
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-09-06
|
|
|
|
40
|
A501BE
|
NUSAR 50MG TAB (EMC/COL) LOSARTAN
|
LOSARTAN
|
NUSAR
|
3X10
|
A
|
2.72
|
0.09
|
TABLET
|
30
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
A501BH
|
LOSARTAN 50MG TAB (HEA/RXP)
|
LOSARTAN
|
LOSARTAN
|
30'S
|
A
|
2.15
|
0.07
|
TABLET
|
30
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
A501BR
|
LOSARTAN 50MG TAB (HEA)
|
LOSARTAN
|
LOSARTAN
|
30'S
|
A
|
2.23
|
0.07
|
TAB
|
30
|
|
HEA
|
HEALTH 2000 INC
|
STO
|
BRYDEN STOKES LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-02-26
|
|
|
|
40
|
A501EK
|
LOSARTAN 50MG TAB (HEA/ATB)
|
LOSARTAN
|
LOSARTAN
|
30'S
|
A
|
2.15
|
0.0717
|
TABLET IMMED
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
oral
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-11-25
|
|
|
|
40
|
A501F
|
DIOVAN 80MG TAB (NVS/COL) VALSARTAN
|
VALSARTAN
|
DIOVAN
|
14'S
|
A
|
9.08
|
0.65
|
TABLET
|
30
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
A501F
|
DIOVAN 80MG TAB (NVS) VALSARTAN
|
VALSARTAN
|
DIOVAN
|
14'S
|
A
|
9.08
|
0.6485
|
TAB
|
30
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
A501F
|
DIOVAN 80MG TAB (NVS) VALSARTAN
|
VALSARTAN
|
DIOVAN
|
14'S
|
A
|
9.08
|
0.65
|
TAB
|
30
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
A501G
|
DIOVAN 160 MG (NVS/COL)
|
VALSARTAN
|
DIOVAN
|
14'S
|
A
|
9.08
|
0.648
|
TABLET
|
30
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD.
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
2024-03-31
|
|
ORAL
|
6
|
CARDIOVASCULAR DRUG
|
2023-08-17
|
|
|
|
41
|
A501HA
|
LOSARTAN 50MG TAB (FSB)
|
LOSARTAN
|
LOSARTAN
|
100'S
|
A
|
6.66
|
0.0666
|
TAB
|
30
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
A501HK
|
COZAAR 50MG TAB (MSD/STO) LOSARTAN
|
LOSARTAN
|
COZAAR
|
15'S
|
C
|
13.32
|
0.89
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
A501HK
|
COZAAR 50MG TAB (MSD) LOSARTAN (C)
|
LOSARTAN
|
COZAAR
|
15'S
|
C
|
13.43
|
0.8952
|
TAB
|
30
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
A501HK
|
COZAAR 50MG TAB (MSD) LOSARTAN
|
LOSARTAN
|
COZAAR
|
15'S
|
C
|
13.43
|
0.90
|
TAB
|
30
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
41
|
A501HZ
|
PRESARTAN 50MG TAB (IPC) LOSARTAN
|
LOSARTAN
|
PRESARTAN
|
100'S
|
A
|
4.19
|
0.0419
|
TAB
|
30
|
BOX
|
IPC
|
IPCA Laboratories Ltd.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
A501JU
|
LOSARTAN 50MG TAB (HEA)
|
LOSARTAN
|
LOSARTAN
|
3X10
|
A
|
2.23
|
0.07
|
TAB
|
30
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2025-10-31
|
|
|
|
42
|
A501KB
|
LOSARTAN 50MG TAB (HEA)
|
LOSARTAN
|
LOSARTAN
|
3X10
|
A
|
2.23
|
0.07
|
TAB
|
30
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-01-26
|
|
|
|
40
|
A5022
|
COZAAR 100MG TAB (MSD/STO) LOSARTAN
|
LOSARTAN
|
COZAAR
|
15'S
|
C
|
18.29
|
1.22
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
A5022
|
COZAAR 100MG TAB (MSD) LOSARTAN (C)
|
LOSARTAN
|
COZAAR
|
15'S
|
C
|
18.48
|
1.2323
|
TAB
|
30
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
A5022
|
COZAAR 100MG TAB (MSD) LOSARTAN
|
LOSARTAN
|
COZAAR
|
15'S
|
C
|
18.48
|
1.23
|
TAB
|
30
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
A5026
|
DIOVAN 320MG (NVS/COL)
|
VALSARTAN
|
DIOVAN
|
14
|
B
|
9.74
|
0.695
|
|
30
|
TABS
|
|
NOVARTIS PHARMACEUTICALS UK LTD.
|
COL
|
COLLINS LTD.
|
B
|
|
|
|
2024-03-31
|
|
|
6
|
|
2023-08-17
|